Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-18 4:52 pm Purchase | 13G | uniQure N.V. QURE | Boxer Capital LLC | 2,500,000 5.1% | 2,500,000 (New Position) | View |
| 2024-05-15 08:37 am Purchase | 13D | iTeos Therapeutics Inc. ITOS | Boxer Capital LLC | 2,946,915 8.1% | 792,857 (+36.81%) | View |
| 2024-04-22 7:24 pm Purchase | 13G | Century Therapeutics Inc. IPSC | Boxer Capital LLC | 4,901,603 5.8% | 4,901,603 (New Position) | View |
| 2024-02-14 4:02 pm Sale | 13G | PMV Pharmaceuticals Inc. PMVP | Boxer Capital LLC | 0 0% | -3,163,795 (Position Closed) | View |
| 2024-02-12 6:06 pm Purchase | 13G | FATE THERAPEUTICS INC FATE | Boxer Capital LLC | 6,171,000 6.3% | 6,171,000 (New Position) | View |
| 2024-02-08 5:10 pm Purchase | 13D | Tyra Biosciences Inc. TYRA | Boxer Capital LLC | 6,448,359 12.3% | 125,000 (+1.98%) | View |
| 2024-01-25 4:31 pm Sale | 13D | Mirati Therapeutics Inc. MRTX | Boxer Capital LLC | 0 0% | -11,661,726 (Position Closed) | View |
| 2024-01-18 4:31 pm Purchase | 13G | Nkarta Inc. NKTX | Boxer Capital LLC | 4,407,350 9% | 4,407,350 (New Position) | View |
| 2023-12-18 4:03 pm Purchase | 13D | Rain Oncology Inc. RAIN | Boxer Capital LLC | 2,933,152 9.9% | 117,590 (+4.18%) | View |
| 2023-10-12 1:07 pm Unchanged | 13D | Mirati Therapeutics Inc. MRTX | Boxer Capital LLC | 11,661,726 15.9% | 0 (Unchanged) | View |
| 2023-08-16 4:28 pm Purchase | 13D | Mirati Therapeutics Inc. MRTX | Boxer Capital LLC | 11,661,726 15.9% | 1,370,879 (+13.32%) | View |
| 2023-05-24 5:31 pm Purchase | 13D | Rain Oncology Inc. RAIN | Boxer Capital LLC | 2,815,562 9.9% | 305,435 (+12.17%) | View |
| 2023-02-14 1:13 pm Sale | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 698,861 2% | -1,540,000 (-68.78%) | View |
| 2023-02-14 1:12 pm Unchanged | 13G | IDEAYA Biosciences Inc. IDYA | Boxer Capital LLC | 2,202,812 4.6% | 0 (Unchanged) | View |
| 2023-02-14 1:10 pm Purchase | 13G | PMV Pharmaceuticals Inc. PMVP | Boxer Capital LLC | 3,163,795 6.9% | 325,559 (+11.47%) | View |
| 2022-11-08 4:31 pm Purchase | 13D | Rain Oncology Inc. RAIN | Boxer Capital LLC | 2,510,127 9.99% | 615,935 (+32.52%) | View |
| 2022-09-19 4:30 pm Purchase | 13G | SpringWorks Therapeutics Inc. SWTX | Boxer Capital LLC | 3,421,541 5.7% | 3,421,541 (New Position) | View |
| 2022-06-15 7:11 pm Unchanged | 13D | Tyra Biosciences Inc. TYRA | Boxer Capital LLC | 6,323,359 15.1% | 0 (Unchanged) | View |
| 2022-05-11 5:14 pm Sale | 13D | iTeos Therapeutics Inc. ITOS | Boxer Capital LLC | 2,154,058 6.1% | -988,000 (-31.44%) | View |
| 2022-03-18 9:00 pm Sale | 13D | iTeos Therapeutics Inc. ITOS | Boxer Capital LLC | 3,142,058 8.9% | -575,201 (-15.47%) | View |